Through the merger agreement, Auris paid $4 per share in cash, which the company said is approximately 39.9% over the closing sale price of the common stock of Hansen Medical as reported in April.
The merger became official yesterday, making Hansen a wholly-owned subsidiary of the stealthy Auris, according to an SEC filing from Hansen Medical.
Current Auris CEO Fred Moll founded Hansen Medical in 2002 with an eye toward the intravascular space. Moll, a serial entrepreneur, also co-founded Mako Surgical, acquired in 2013 by Stryker Corp. and Restoration Robotics and its Artas hair restoration platform.
Former Hansen CEO Cary Vance and CFO Cristopher Lowe resigned as officers of the company with the merger, putting Moll back in corner office of the company he originally founded.
Mountain View, Calif.-based Hansen has a pair of platforms on the market: The Sensei system for electrophysiology procedures and the Magellan system for peripheral vascular interventions.
Redwood City, Calif.-based Auris is developing a surgical robot for ophthalmological procedures, but has not released any details surrounding the device. The acquisition will put 3 different robotic systems under Auris’ control.
As part of the deal, certain significant Hansen Medical stockholders said they will invest approximately $49 million into Auris upon the closing of the transaction.
The deal was originally announced in April.
On December 11-12,DeviceTalks West is taking over Orange County's medtech industry with one of the most anticipated conferences of the winter, bringing you the best and brightest minds in the industry.
Dr. Robert Greenberg, Executive Chairman, Alfred E. Mann Foundation
Gary Guthart, President and Chief Executive Officer, Intuitive Surgical
Reggie Groves, CEO, REVA Medical
Use code KEYNOTE to save an additional 10%.